Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-28

Clinical Trial Update: Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cemiplimab in combination with transarterial radioembolization using Y-90 SIR-Spheres for liver-directed metastatic breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cemiplimab (cemiplimab)
  • SIR-Spheres Y-90 microspheres (yttrium-90 microspheres)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 2 | Status: RECRUITING